2002; Barbusinski 2009; Buschini et al. 2011). Enhanced levels of MPO and its oxidative products were reported in macular degeneration and cataractogenesis (Yugai et al. 1992; Marsili et al. 2004; Michal et al. 2010). This evidence concerns the gene MPO and macular degeneration.